Infusion Device securely transmits patient data.May 11, 2007 -
Plum A+® single-channel medication infusion device helps secure patient data against inadvertent release by securely transferring data between device and hospital information technology systems as part of the intravenous medication administration process. It offers encryption and authentication capabilities via 802.11a, 802.11b, and 802.11g wireless modes.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release
Hospira Worldwide, Inc.
275 N. Field Dr.
Lake Forest, IL, 60045
USA
Hospira Introduces Advanced Wireless Security Platform for Infusion Devices
Industry's First Infusion Pumps to Offer Advanced Encryption and Authentication Capabilities Via 802.11 "a," "b" and "g" Wireless Modes
LAKE FOREST, Ill., April 4 /- Hospira, Inc. (NYSE:HSP), a leading global hospital products company, today introduced a new wireless platform for its medication infusion devices that incorporates leading-edge authentication standards and encryption protocols to assist hospitals in securely transferring data and complying with patient confidentiality regulations. The new technology also provides the first three- in-one wireless multi-band module for an infusion system, enabling hospitals to select any of three frequency modes for communication.
The platform's expanded security options help ensure only designated, approved hospital staff access clinical data transmitted between the devices and hospital information technology systems as part of the intravenous (I.V.) medication administration process. This can help healthcare providers more readily comply with patient confidentiality regulations, such as the Health Insurance Portability and Accountability Act, or HIPAA, in securing patient data against inadvertent release.
"Hospira is pleased to be the first to offer hospitals advanced security options and multi-mode flexibility, allowing them to optimize their wireless communications," said Symeria Hudson, vice president, Marketed Products, Global Devices. "By helping ensure secure, unimpeded data exchange, Hospira's new offering will help hospitals improve the efficiency of their information technology infrastructure today, while reducing the need for future upgrades."
Most wireless products -- such as mobile phones, pagers and other medical devices -- communicate via the 802.11 "b" or "g" modes on the 2.4 GHz band. With Hospira's new platform, hospitals can choose to operate the company's infusion devices in the "b" or "g" modes, as well as the less frequently used "a" (5 GHz band) wireless mode, to help ensure clear, consistent data transmission.
"At Virtua Health, wireless technologies play a key role in communicating patient and clinical data in real-time," said John Bloomer, chief information officer, Virtua Health. "Our hospital is committed to providing an outstanding patient experience, and we are pleased that Hospira's new offering will provide a safe and timely conduit for information, meeting leading encryption and authentication standards."
Hospira is currently offering this new capability with the Plum A+® single-channel infusion device and will be adding it to its Plum A+®3 triple-channel device, LifeCare PCA® patient-controlled analgesia system and Symbiq(TM) infusion system later this year. The devices work in conjunction with the Hospira MedNet® system, a scaleable and upgradeable patient safety platform. More than 400,000 Hospira infusion pumps are installed in hospitals worldwide today.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the productivity, safety and efficacy of patient care. In February 2007, Hospira acquired Mayne Pharma Limited to become the world leader in specialty generic injectable pharmaceuticals. With 70 years of service to the hospital industry, Hospira's portfolio includes one of the industry's broadest lines of generic acute-care and oncology injectables, which help address the high cost of proprietary pharmaceuticals; and integrated solutions for medication management and infusion therapy. Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately 15,000 employees and 18 manufacturing facilities worldwide. Hospira's news releases and other information can be found at www.hospira.com.
Source: Hospira, Inc.
CONTACT:
Media,
Jason Hodges,
+1-224-212-2863,
of Hospira, Inc.
Web site: http://www.hospira.com/
|
|
|
|
|
|
|
| 
